SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

SVB Leerink Maintains Outperform on Seattle Genetics, Raises Price Target to $167

SVB Leerink analyst Andrew Berens maintains Seattle Genetics (NASDAQ:SGEN) with a Outperform and raises the price target from $155 to $167.

Benzinga · -
SVB Leerink analyst Andrew Berens maintains Seattle Genetics (NASDAQ: SGEN) with a Outperform and raises the price target from $155 to $167.